197 related articles for article (PubMed ID: 22156337)
21. [Prion protein structure and its relationships with pathogenesis].
Muramoto T
Rinsho Shinkeigaku; 2003 Nov; 43(11):813-6. PubMed ID: 15152472
[TBL] [Abstract][Full Text] [Related]
22. The novel sorting nexin SNX33 interferes with cellular PrP formation by modulation of PrP shedding.
Heiseke A; Schöbel S; Lichtenthaler SF; Vorberg I; Groschup MH; Kretzschmar H; Schätzl HM; Nunziante M
Traffic; 2008 Jul; 9(7):1116-29. PubMed ID: 18419754
[TBL] [Abstract][Full Text] [Related]
23. Pathogenic prions deviate PrP(C) signaling in neuronal cells and impair A-beta clearance.
Pradines E; Hernandez-Rapp J; Villa-Diaz A; Dakowski C; Ardila-Osorio H; Haik S; Schneider B; Launay JM; Kellermann O; Torres JM; Mouillet-Richard S
Cell Death Dis; 2013 Jan; 4(1):e456. PubMed ID: 23303130
[TBL] [Abstract][Full Text] [Related]
24. Production of seedable Amyloid-β peptides in model of prion diseases upon PrP
Ezpeleta J; Baudouin V; Arellano-Anaya ZE; Boudet-Devaud F; Pietri M; Baudry A; Haeberlé AM; Bailly Y; Kellermann O; Launay JM; Schneider B
Nat Commun; 2019 Aug; 10(1):3442. PubMed ID: 31371707
[TBL] [Abstract][Full Text] [Related]
25. Cellular prion protein: A co-receptor mediating neuronal cofilin-actin rod formation induced by β-amyloid and proinflammatory cytokines.
Walsh KP; Kuhn TB; Bamburg JR
Prion; 2014; 8(6):375-80. PubMed ID: 25426519
[TBL] [Abstract][Full Text] [Related]
26. Protease-sensitive synthetic prions.
Colby DW; Wain R; Baskakov IV; Legname G; Palmer CG; Nguyen HO; Lemus A; Cohen FE; DeArmond SJ; Prusiner SB
PLoS Pathog; 2010 Jan; 6(1):e1000736. PubMed ID: 20107515
[TBL] [Abstract][Full Text] [Related]
27. Activation of zebrafish Src family kinases by the prion protein is an amyloid-β-sensitive signal that prevents the endocytosis and degradation of E-cadherin/β-catenin complexes in vivo.
Sempou E; Biasini E; Pinzón-Olejua A; Harris DA; Málaga-Trillo E
Mol Neurodegener; 2016 Feb; 11():18. PubMed ID: 26860872
[TBL] [Abstract][Full Text] [Related]
28. Prions, prionoids and pathogenic proteins in Alzheimer disease.
Ashe KH; Aguzzi A
Prion; 2013; 7(1):55-9. PubMed ID: 23208281
[TBL] [Abstract][Full Text] [Related]
29. Role of lipid rafts in the processing of the pathogenic prion and Alzheimer's amyloid-beta proteins.
Taylor DR; Hooper NM
Semin Cell Dev Biol; 2007 Oct; 18(5):638-48. PubMed ID: 17822928
[TBL] [Abstract][Full Text] [Related]
30. The neurodegeneration in Alzheimer disease and the prion protein.
Forloni G; Sclip A; Borsello T; Balducci C
Prion; 2013; 7(1):60-5. PubMed ID: 23324596
[TBL] [Abstract][Full Text] [Related]
31. Tumor necrosis factor-α reduces beta-amyloid accumulation primarily by lowering cellular prion protein levels in a brain endothelial cell line.
Yasutaka Y; Watanabe T; Nakashima A; Matsumoto J; Futagami K; Yamauchi A; Kataoka Y
FEBS Lett; 2015 Jan; 589(2):263-8. PubMed ID: 25497018
[TBL] [Abstract][Full Text] [Related]
32. The role of the cellular prion protein in the uptake and toxic signaling of pathological neurodegenerative aggregates.
Scialò C; Legname G
Prog Mol Biol Transl Sci; 2020; 175():297-323. PubMed ID: 32958237
[TBL] [Abstract][Full Text] [Related]
33. Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death.
Kudo W; Lee HP; Zou WQ; Wang X; Perry G; Zhu X; Smith MA; Petersen RB; Lee HG
Hum Mol Genet; 2012 Mar; 21(5):1138-44. PubMed ID: 22100763
[TBL] [Abstract][Full Text] [Related]
34. Distinct prion-like strains of amyloid beta implicated in phenotypic diversity of Alzheimer's disease.
Cohen M; Appleby B; Safar JG
Prion; 2016; 10(1):9-17. PubMed ID: 26809345
[TBL] [Abstract][Full Text] [Related]
35. Targeting of the prion protein to the cytosol: mechanisms and consequences.
Miesbauer M; Rambold AS; Winklhofer KF; Tatzelt J
Curr Issues Mol Biol; 2010; 12(2):109-18. PubMed ID: 19767654
[TBL] [Abstract][Full Text] [Related]
36. Cellular prion protein offers neuroprotection in astrocytes submitted to amyloid β oligomer toxicity.
Marques CMS; Gomes RN; Pedron T; Batista BL; Cerchiaro G
Mol Cell Biochem; 2023 Aug; 478(8):1847-1865. PubMed ID: 36576715
[TBL] [Abstract][Full Text] [Related]
37. Genes contributing to prion pathogenesis.
Tamgüney G; Giles K; Glidden DV; Lessard P; Wille H; Tremblay P; Groth DF; Yehiely F; Korth C; Moore RC; Tatzelt J; Rubinstein E; Boucheix C; Yang X; Stanley P; Lisanti MP; Dwek RA; Rudd PM; Moskovitz J; Epstein CJ; Cruz TD; Kuziel WA; Maeda N; Sap J; Ashe KH; Carlson GA; Tesseur I; Wyss-Coray T; Mucke L; Weisgraber KH; Mahley RW; Cohen FE; Prusiner SB
J Gen Virol; 2008 Jul; 89(Pt 7):1777-1788. PubMed ID: 18559949
[TBL] [Abstract][Full Text] [Related]
38. Autophagy induction by trehalose counteracts cellular prion infection.
Aguib Y; Heiseke A; Gilch S; Riemer C; Baier M; Schätzl HM; Ertmer A
Autophagy; 2009 Apr; 5(3):361-9. PubMed ID: 19182537
[TBL] [Abstract][Full Text] [Related]
39. Prion degradation pathways: Potential for therapeutic intervention.
Goold R; McKinnon C; Tabrizi SJ
Mol Cell Neurosci; 2015 May; 66(Pt A):12-20. PubMed ID: 25584786
[TBL] [Abstract][Full Text] [Related]
40. Context dependent neuroprotective properties of prion protein (PrP).
Steele AD; Zhou Z; Jackson WS; Zhu C; Auluck P; Moskowitz MA; Chesselet MF; Lindquist S
Prion; 2009; 3(4):240-9. PubMed ID: 19901559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
